mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.039 |
0.2 |
mRNA |
Doxorubicin |
GDSC1000 |
pan-cancer |
AAC |
-0.04 |
0.2 |
mRNA |
TGX221 |
CTRPv2 |
pan-cancer |
AAC |
0.042 |
0.2 |
mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.042 |
0.2 |
mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
-0.041 |
0.2 |
mRNA |
LY-2157299 |
CTRPv2 |
pan-cancer |
AAC |
-0.092 |
0.2 |
mRNA |
GDC-0449 |
GDSC1000 |
pan-cancer |
AAC |
-0.04 |
0.3 |
mRNA |
pifithrin-mu |
CTRPv2 |
pan-cancer |
AAC |
-0.039 |
0.3 |
mRNA |
COL-3 |
CTRPv2 |
pan-cancer |
AAC |
-0.041 |
0.3 |
mRNA |
BAY 61-3606 |
GDSC1000 |
pan-cancer |
AAC |
0.038 |
0.3 |